Muutke küpsiste eelistusi

Advances in Microbiology, Infectious Diseases and Public Health: Volume 2 Softcover Reprint of the Original 1st 2016 ed. [Pehme köide]

  • Formaat: Paperback / softback, 134 pages, kõrgus x laius: 254x178 mm, kaal: 454 g, 40 Illustrations, color; VI, 134 p. 40 illus. in color., 1 Paperback / softback
  • Sari: Advances in Microbiology, Infectious Diseases and Public Health 901
  • Ilmumisaeg: 31-May-2018
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319802429
  • ISBN-13: 9783319802428
Teised raamatud teemal:
  • Pehme köide
  • Hind: 150,61 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 177,19 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Paperback / softback, 134 pages, kõrgus x laius: 254x178 mm, kaal: 454 g, 40 Illustrations, color; VI, 134 p. 40 illus. in color., 1 Paperback / softback
  • Sari: Advances in Microbiology, Infectious Diseases and Public Health 901
  • Ilmumisaeg: 31-May-2018
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3319802429
  • ISBN-13: 9783319802428
Teised raamatud teemal:
This Series will provide microbiologists, hygienists, epidemiologists and infectious diseases specialists with well-chosen contributed volumes containing updated information in the areas of basic and applied microbiology involving relevant issues for public health, including bacterial, fungal and parasitic infections, zoonoses and anthropozoonoses, environmental and food microbiology.





The increasing threat of the multidrug-resistant microorganisms and the related host immune response, the new strategies for the treatment of biofilm-based, acute and chronic microbial infections, as well as the development of new vaccines and more efficacious antimicrobial drugs to prevent and treat human and animal infections will be also reviewed in this series in the light of the most recent achievements in these fields.





Special attention will be devoted to the fast diffusion worldwide of the new findings of the most advanced translational researches carried out in the different fieldsof microbiological sciences, with the aim to promote a prompt validation and transfer at clinical level of the most promising experimental results.
Overview of the antimicrobial activity of 19 essential
oils.- Refractory Trichophyton rubrum infections in Turin, Italy: a problem
still present.- Antioxidant hydroxytyrosol-based polyacrylate with
antimicrobial and antiadhesive activity versus Staphylococcus
epidermidis.- The role of human Herpesvirus 8 in diabetes mellitus type 2:
state of the art and a medical hypothesis.- Prevalence of Chlamydia
trachomatis, Trichomonas vaginalis and Neisseria gonorrhoeae based on data
collected by a network of clinical microbiology laboratories, in
Italy.- -defensins: work in progress.- Emergence of Escherichia
coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8
carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in
Northern Italy.- Carbapenem-resistant Klebsiella pneumoniae: results of a
laboratory surveillance program in an Italian General Hospital (August
2014-January 2015).- A snapshot of drug-resistant M. tuberculosis strains in
Croatia.- Quorum quenching strategy targeting gram-positive pathogenic
bacteria.